WuXi Biologics (Cayman) Inc
HKEX:2269
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
CN |
|
Cineverse Corp
NASDAQ:CNVS
|
US |
|
IHI Corp
TSE:7013
|
JP |
|
Mitsubishi Corp
TSE:8058
|
JP |
Wall St Price Targets
Price Targets Summary
WuXi Biologics (Cayman) Inc
According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 45.29 HKD with a low forecast of 30.3 HKD and a high forecast of 81.63 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is WuXi Biologics (Cayman) Inc's stock price target?
Price Target
45.29
HKD
According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 45.29 HKD with a low forecast of 30.3 HKD and a high forecast of 81.63 HKD.
What is the Revenue forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
12%
Over the last 10 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 8 years is 12%.
What is the Operating Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
15%
Over the last 10 years, the compound annual growth rate for Operating Income has been 61%. The projected CAGR for the next 8 years is 15%.
What is the Net Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
13%
Over the last 10 years, the compound annual growth rate for Net Income has been 60%. The projected CAGR for the next 8 years is 13%.
